Search

everythinglearnresearchcommunity

for

Search:↓

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The assay effectively identifies compounds that affect immune cell activation.

A genetic mutation in the LIPH gene causes a rare hair disorder with sparse, curly hair.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

A man with a rare lung-focused form of hypereosinophilic syndrome improved with steroid treatment.

Some people with Frontal Fibrosing Alopecia may be allergic to a common sunscreen ingredient.

Basaloid follicular hamartoma is a rare, benign skin growth often misdiagnosed.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

The 2012 criteria are better for diagnosing atypical lupus cases.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

The study found that males with KFSD had severe skin and eye symptoms, while female carriers had milder symptoms.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Follicular unit hair transplantation is the standard method for natural-looking hair restoration in androgenic alopecia.

Flutamide alone is as effective as the combination with finasteride for treating hirsutism.